Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 30

Results For "trend"

334 News Found

Expectations and predictions for 2022
Opinion | December 28, 2021

Expectations and predictions for 2022

In India, healthcare has become one of the fastest-growing economic sectors which comprise hospitals, pharma companies, medical equipment and devices, medical tourism, health insurance, clinical trials etc


Biocon partner Equillium initiates clinical study for Itolizumab in Lupus Nephritis
Biotech | December 24, 2021

Biocon partner Equillium initiates clinical study for Itolizumab in Lupus Nephritis

Systemic Lupus Erythematosus, or Lupus, is an autoimmune chronic inflammatory disease. The prevalence of SLE in the U.S. has been reported to be between 20 to 150 cases per 100,000. In India, the reported prevalence of SLE is 3.2 per 100,000


NMPA approves CStone's NDA for Cejemly
Drug Approval | December 21, 2021

NMPA approves CStone's NDA for Cejemly

The NMPA approval is based on the positive data of GEMSTONE-302 study, a multi-center, randomized, double-blind, phase III study that evaluated the efficacy and safety of Cejemly or placebo in combination with chemotherapy in first-line stage IV NSCLC patients


Most national diagnostic players to deliver double-digit revenue growth in FY2022: ICRA
News | December 15, 2021

Most national diagnostic players to deliver double-digit revenue growth in FY2022: ICRA

During H1 FY2022, the revenues and operating profit margin (OPM) for ICRA sample set showed sharp improvement aided by volume uptick in Covid-19 and allied tests and also demand traction for non-Covid tests


KOREA PACK and ICPI to be held in June 2022 in hybrid format
Packaging | December 13, 2021

KOREA PACK and ICPI to be held in June 2022 in hybrid format

KOREA PACK and concurrent event ICPI Week (Int’l Cosmetic and Pharmaceutical Industry Week) will be held as hybrid events in 2022


IPM registers 6 % yoy revenue growth in Nov 2021.
News | December 08, 2021

IPM registers 6 % yoy revenue growth in Nov 2021.

Ind-Ra expects IPM revenue growth of over 12% yoy for FY22.


North America accounts for 50 % of generic pharma market
News | December 03, 2021

North America accounts for 50 % of generic pharma market

Going forward, the fastest-growing regions in the generic pharmaceuticals market will be South America and the Middle East, where growth will be at CAGRs of 10.1% and 9.4% respectively


GSK's antibody drug sotrovimab works against Omicron mutations
Biotech | December 02, 2021

GSK's antibody drug sotrovimab works against Omicron mutations

Preclinical data demonstrate sotrovimab, authorised in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron


Conference highlights opportunities in the nursing profession
News | November 30, 2021

Conference highlights opportunities in the nursing profession

This collaborative nursing conference generated a positive dialogue on how the healthcare space of nursing has evolved in the past year